Medicinal Chemistry & Biology West Coast 2021

Medicinal Chemistry & Biology

Strategy Meeting Online West Coast 2021

Unlike typical conferences, the Proventa International Strategy Meeting format is interactive and informal, where industry leaders can share insight and explore new partnerships. This virtual conference format allows you to discuss key medicinal chemistry & biology issues with your peers and forge new connections from the comfort of your own home.

25th May 2021
Online

Strategy meetings

Medicinal Chemistry & Biology insights without leaving your home

Need a unique online conference experience? Looking for a chance for real discussions and genuine networking? Proventa International’s online R&D strategy meetings help you make those important connections through interactive roundtable discussions and keynote panel debates – all in a totally online format. Join biology and medicinal chemistry professionals from all over the West Coast, USA. Engage with your senior peers, discover new insights and help take your company to the next level.

Strategy Meetings

What makes our strategy meetings unique?

No other event creates such a unique and personalised event experience. From the tailored agenda, to the senior delegation; our online strategy meetings provide the perfect learning and networking environment from the comfort of your own home or office.

Roundtable Discussions

Intimate discussions lead by a renowned expert. Have your voice heard alongside like-minded life science executives.

Unrivalled Networking

With senior delegation from big pharma and innovative biotech from all over the globe, you can network with peers from different locations, all in one place.

Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Totally Online Format

It’s more important than ever to encourage collaboration while promoting safety and accessibility. And that’s exactly what you can expect from our online meeting format.

Meet the Facilitators

Our panel of facilitators play a key role in shaping the agenda. See who will be bringing their expertise to the 2021 Strategy Meeting:

Peter Kotsonis

Executive Director, Office of Strategic Alliances, UCSF Innovation Ventures University of California

PhD MRACI CChem MCPM
Executive Director and Head of Strategic Alliances, UCSF Innovation Ventures, University of California, San Francisco
PhD neuroscientist and “drug hunter”, business development / alliance professional with over 14 years in the pharmaceutical industry. From 1997-1999, project leader of the nitric oxide synthase program at VasoPharm Biotech GmbH (academic start up) resulting in first-in-class clinical candidate, ronopternin (VAS203), for traumatic brain injury currently in Phase III clinical development. From 2000-2006 in various R&D roles at Novartis Ag, including research group leader and a migraine project leader. From 2007-2012 at Sunovion Pharmaceuticals (subsidiary of Dainippon Sumitomo Pharma Co, Ltd) as the head operations and alliance function for the Discovery and Early Clinical Research group; primarily involved in defining research strategy, portfolio management and, establishing an external innovation strategy. Joined UCSF in 2013 within the Office of Innovation, Technology and Alliances. Responsibilities include driving new partner opportunities, developing novel partnering models and, programmatic support using alliance management “best practices” comparable to industry.

Tudor Oprea

Professor of Medicine and Chief, Translational Informatics Division, Department of Internal Medicine University of New Mexico

Uli Schmitz

Executive Director, Structural Chemistry Gilead Sciences

Paul Galatsis

VP, Chemistry Vibliome Therapeutics

Mike Petrassi

VP, Medicinal Chemistry Calibr/Scripps Research

Yuhua Ji

Head of Medicinal Chemistry Zai Lab US

Syed Askari

Founder and CEO Maculus Therapeutix

Prasun Mishra

CEO Agility Pharmaceuticals

Yvonne Will

VP, Predictive and Investigative Toxicology (Nonclinical Safety) Janssen R&D LLC

Vice President, Predictive, Investigative and Translational Toxicology, Non-clinical Safety (NCS), Janssen Yvonne joined Janssen in Q4 of 2019 and is based in La Jolla. She leads an integrated team of investigators. laboratory-based scientists across all global NCS regions in the development of predictive safety and rapid issue resolution tools, primarily safety pharmacology, molecular/cell biology, biochemical, genetics, expression, and investigative in vivo models representing human target organ biology. Yvonne is a biochemist with 20 years’ experience in large pharma and biotech. Her expertise is diverse and spans a wide range of drug discovery areas, including discovery biology, chemistry, discovery toxicology and technology implementation. Yvonne is nationally and internationally recognized through her publication record and her extensive collaborations. She is credited with more than 70 publications, 20+invited chapters, 100+ invited presentations and has edited four books. She received the Connecticut Women in Innovation and Leadership Award (2013) and is a Fellow of the Academy of Toxicological Sciences (2015). Yvonne obtained her Master of Science and PhD degrees in Biochemistry and Biophysics from Oregon State University.

Vuong Trieu

Chairman & CEO Mateon Therapeutics

Mathias Schmidt

CEO ArmaGen Inc

Danilo Maddalo

Head of Laboratory Roche

Werner Rubas

Executive Director Nektar Therapeutics

Cathy Tralau-Stewart

Senior Director Alliances Takeda

Nick Shah

Head of In Vitro Pharmacology DiCE Molecules

Reasons to Attend the Virtual Conference

Fully Interactive Virtual Conference

We’re all bored of the same webinar format by now. Instead, join intimate groups of like-minded professionals and discuss the topics that really matter to you

Personalised and Easy to Join Agenda

Pick the roundtable discussions that you want to be part of. Simply choose your sessions and we will send you the direct links and calendar reminder to join

Senior Decision Makers

All our roundtable discussions are aimed at director level and above. Discover how your peers are tackling the industries biggest challenges and have your thoughts heard

Private and Intimate Discussions

Each sessions is read by an industry expert and the roundtables are limited to ensure you have fruitful and genuine conversations with your colleagues

Agenda

See Which Topics Are Up For Discussion

08:00 PDT

Opening Keynote and welcome address

08:30 PDT

08:45 PDT

Roundtable Tracks

Artificial Intelligence / Machine Learning Chemical Biology & Cheminformatics Design & Custom Synthesis Hit To Lead Identification Integrated Drug Discovery In Vivo & In Vitro Pharmacology Target Discovery, Identification & Validation Dmpk, Adme & Toxicology Strategic Partnerships, Collaborations & Alliance Management

09:45 PDT

10:00 PDT

10:30 PDT

10:45 PDT

Roundtable Tracks

11:45 PDT

12:00 PDT

12:30 PDT

12:45 PDT

Roundtable Tracks

13:45 PDT

14:00 PDT

Roundtable Tracks

15:00 PDT

Our 2021 Associate Sponsor

Our 2021 Co-Hosts

Quick Links

See what’s next

Find out more details about our Strategy Meetings and other news and events

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

R&D R&D Online West Coast

Medicinal Chemistry & Biology Strategy Meeting